Macy's Inc (M) Stock News

A securities fraud class action lawsuit has been filed against Microsoft Corporation for allegedly misleading investors about its Copilot AI chatbot and Azure cloud platform capabilities. The stock dropped 10% on January 28, 2026, after Microsoft revealed disappointing Azure growth and disclosed that Microsoft 365 Copilot premium customers totaled only 15 million, materially below analyst estimates. The Wall Street Journal subsequently reported that Copilot faced severe functionality issues and market share losses due to confusing brand positioning and interoperability problems.

The global deep learning market is projected to grow from $125.41 billion in 2025 to $1,963.25 billion by 2035, with a CAGR of 31.69%. Growth is driven by generative AI adoption, enterprise automation, and increased AI infrastructure investments across healthcare, finance, automotive, and industrial sectors. The U.S. market is expected to expand from $37.14 billion to $596.02 billion, while Europe grows from $31.98 billion to $451.64 billion.

The global ovarian cancer diagnostics market is valued at USD 4.92 billion in 2025 and is projected to reach USD 8.08 billion by 2035, growing at a CAGR of 5.06%. Growth is driven by rising ovarian cancer incidence, increasing adoption of AI-powered imaging, biomarker testing, and precision oncology diagnostics. North America leads with 41.2% market share, while imaging and hospital laboratories dominate their respective segments.

The global Citizen Services AI Market is expected to grow from $19.24 billion in 2025 to $601.18 billion by 2035 at a 41.13% CAGR. Growth is driven by digital government transformation mandates, demand for personalized citizen services, and AI-powered solutions for public service delivery. The U.S. market leads globally, projected to reach $256.42 billion by 2035, while Europe is expected to grow to $144.86 billion. Key applications include AI chatbots, fraud detection, and smart governance platforms.

The global Smart Electric Meter Market is projected to grow from USD 27.24 billion in 2025 to USD 59.22 billion by 2035, expanding at a CAGR of 8.27%. Growth is driven by smart grid modernization, utility digitalization, and advanced metering infrastructure deployment. Asia Pacific leads with 45.19% market share, while single-phase smart meters dominate at 68.29% of revenue. Key players include Landis+Gyr, Itron Inc., Siemens AG, and Schneider Electric.

The global microcatheter market is valued at USD 1.05 billion in 2025 and is projected to reach USD 1.79 billion by 2035, expanding at a CAGR of 5.53%. Growth is driven by increasing adoption of minimally invasive cardiovascular and neurovascular procedures, rising prevalence of cardiovascular and neurovascular disorders, and advancements in catheter technologies. Aspiration microcatheters lead with 36% market share, while steerable microcatheters are the fastest-growing segment. North America dominates with 34% of global revenues, with Asia-Pacific emerging as the fastest-growing region.

Investec Bank plc, acting as Advisor & Joint Broker to Advanced Medical Solutions Group Plc, disclosed public dealing in ordinary shares on 18th June 2026. The exempt principal trader purchased 109,174 shares at prices between 227-229 per unit and sold 59,174 shares at prices between 227-227.5 per unit.

MOVA showcased its expanded residential energy storage portfolio at Intersolar Europe 2026, featuring the debut of the LumeGret S4800 plug-and-play system with up to 25kWh capacity and integrated EV charging. The company also officially launched the flagship A4000 model for sale and displayed the A2000 system, offering scalable solutions across different household sizes and applications.

The next wave of AI adoption is shifting from tool-builders to companies applying AI in real-world drug development. Eli Lilly leverages AI partnerships with OpenAI and Nvidia for drug discovery while expanding its weight-loss portfolio, showing strong financial growth. Twist Bioscience supplies synthetic DNA for drug testing and benefits from Amazon's new Bio Discovery platform, offering higher-risk growth potential.

The global potash fertilizers market is projected to grow from $27.96 billion in 2025 to $48.98 billion by 2035 at a CAGR of 5.18%, driven by rising global food demand, soil potassium depletion, and increased adoption of precision agriculture. Potassium chloride (MOP) dominates with 62% market share, while potassium nitrate shows fastest growth. Asia Pacific leads regional consumption with China accounting for 44.8% of the region's revenues.

Nvidia and AMD are both benefiting from the AI revolution, with Nvidia leading in GPUs and AMD traditionally strong in CPUs. As AI evolves into agentic AI and robotics, Nvidia is positioning itself to dominate GPUs and robotics while potentially challenging AMD's CPU leadership, though AMD may retain strength in PC markets.

ISS announced its Capital Markets Day scheduled for September 14, 2026, in Copenhagen. The event will feature executive management presentations on strategy, commercial momentum, and financial outlook, including a customer site tour. Key topics include North America operations, customer-centric growth, operational efficiency, and workforce management. Registration deadline is September 1, 2026.

The global SRAM and ROM Design IP market, valued at $644.97 million in 2025, is expected to grow to $784.47 million by 2035 at a CAGR of 1.98%. Growth is driven by rising demand for AI, chiplet-based architectures, and advanced semiconductor memory solutions. Embedded Flash/NVM dominates with 54% market share, while MRAM is the fastest-growing segment at 9.20% CAGR. Asia-Pacific leads regionally with 40.5% of global revenue.

Defiance ETFs has launched the Defiance Memory UCITS ETF (ticker: DRAM), Europe's first memory-focused ETF, providing exposure to memory semiconductor and data storage companies. The ETF addresses growing demand from AI, cloud computing, and data centers, with memory prices expected to rise significantly by end of 2026. The product is listed on Xetra and Borsa Italiana with London Stock Exchange to follow.

U.S. equity markets showed mixed performance with the S&P 500 and Nasdaq gaining ground, while Bitcoin declined 2.46%. The Semiconductor Index surged 72% above its 200-day moving average, presenting potential overvaluation concerns. The Russell 2000 showed bullish signals, while the Dow Jones displayed bearish patterns. Analysts warn of significant divergences between semiconductor strength and Bitcoin weakness, with limited opportunities for long-term investors.

The Vanguard U.S. Momentum Factor ETF (VFMO) has returned 24% in 2026, more than double the S&P 500's return, by using a rules-based strategy that buys stocks with sustained upward momentum over the last 12 months. Since its 2018 inception, the ETF has delivered a compound annual return of 15.7%, consistently beating the S&P 500's 12.7% average annual return. The strategy automatically identifies winning stocks across sectors without requiring investor guesswork.

Rosen Law Firm is reminding investors who purchased Verra Mobility Corporation (VRRM) stock between February 24, 2026 and May 26, 2026 of an August 4, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Verra made materially false and misleading statements regarding its relationship with Avis Budget Group and contract extension prospects, while downplaying risks of major rental car companies developing in-house solutions.

The Rosen Law Firm is investigating potential securities claims against Disc Medicine, Inc. (NASDAQ: IRON) following an FDA Complete Response Letter on February 13, 2026, regarding its bitopertin program. The FDA stated it could not approve the new drug application due to uncertainties requiring additional evidence. Disc Medicine's stock price fell 22% on the news. The firm is preparing a class action lawsuit to recover investor losses.

The global automated liquid handling systems market is valued at USD 2.7 billion in 2025 and is projected to reach USD 6.9 billion by 2035, growing at a CAGR of 9.8%. Growth is driven by increasing pharmaceutical R&D, clinical trials, technological advancements, and demand for automation in diagnostics and molecular testing. Key players include Eppendorf SE, PerkinElmer Inc., Thermo Fisher Scientific Inc., and QIAGEN NV.

Rosen Law Firm is notifying investors in Calix, Inc., Erasca, Inc., and Graphic Packaging Holding Company of ongoing securities class action lawsuits. The firm is seeking lead plaintiffs with a July 27, 2026 deadline. Calix investors are accused of making false statements regarding profit margins related to memory component purchasing, while the firm encourages investors with losses exceeding $100,000 to seek legal counsel.

InnSuites Hospitality Trust (IHT) reported Fiscal Q1 2027 net income of $74,702, a $35,672 improvement year-over-year, with record hotel revenue of $2.2 million and combined occupancy reaching 85.37%. The company continues exploring diversification opportunities including a potential reverse merger, IBC Hotels independent hotel services, and investments in UniGen Power's clean energy technology.

Federal Reserve Chairman Kevin Warsh's first meeting resulted in steady interest rates with hints of future rate hikes. Steady to higher rates are expected to benefit big banks by widening profit margins on loans versus deposits, though investment banks also benefit from the stable environment for IPOs. The Fed must balance inflation control with avoiding recession.

Amazon is reportedly in early talks to sell its custom Trainium AI chips to external customers, potentially competing with Nvidia's dominant GPU market. However, analysts suggest the threat is manageable as Nvidia's data center revenue continues accelerating at 92% YoY growth, and Amazon itself remains one of Nvidia's largest customers, indicating the AI market is large enough to support both competitors.

AlphaPepe announced its first centralized exchange partnership with Azbit and confirmed additional CEX arrangements are underway. The presale has raised $1.65 million with over 8,600 holders at a token price of $0.01953. The project has completed a security audit and is developing AlphaSwap, an AI-powered decentralized exchange.

SpaceX and Tesla, both led by Elon Musk, have overlapping projects in AI processors and enterprise software that could justify a merger. While such a deal would require board and shareholder approval and could create operational efficiencies, SpaceX's valuation is extremely expensive at a P/S ratio of 130 compared to the tech average of 10. Analysts suggest a merger could occur within a year, but investors should be cautious about SpaceX's current valuation and unproven track record.

PEMCO Mutual Insurance has partnered with Moen to provide members access to the Moen Flo Shutoff smart water monitoring device at a preferred rate. The technology detects leaks early and automatically shuts off water to prevent damage. PEMCO members who install the system may receive up to $1,000 annually toward covered plumbing repairs. Studies show homes with Flo installed experience 96% fewer water damage claim events.

Rosen Law Firm is reminding investors who purchased Erasca, Inc. (NASDAQ: ERAS) stock between January 14, 2025 and April 26, 2026 of an August 10, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Erasca and its executives made false and misleading statements about its lead oncology drug candidate ERAS-0015, including improper comparisons to a competing drug that lacked reasonable basis and exposed the company to patent disputes.

Law firm Johnson Fistel is investigating Certara, Inc. (NASDAQ: CERT) on behalf of investors who suffered losses following the company's May 2026 earnings report disclosing declining services revenue and bookings, along with execution challenges. The investigation was further prompted by the announcement of CFO John Gallagher's resignation effective July 14, 2026. Investors who purchased Certara securities and experienced losses are encouraged to contact the firm.

Pfizer stock fell 2.74% following the announcement that CFO Dave Denton will depart in August, raising investor concerns about leadership continuity and the company's ability to meet 2026 guidance. While recent drug approvals strengthen the pipeline, the CFO transition creates uncertainty around financial execution and earnings recovery.

CarMax stock surged 13% on Thursday following positive analyst upgrades, despite initial negative investor reaction to its Q1 fiscal 2027 earnings. The company beat top and bottom-line expectations with 6% year-over-year top-line growth. Key upgrades included Stephens analyst Jeff Lick raising his rating to overweight with a $66 price target (up from $43), and Baird raising its target to $55 from $48.